The company faces significant risks associated with conducting business internationally, including reliance on third-party manufacturers, which can affect operational efficiency and business performance. The company's ability to innovate and develop new products is critical, as substantial competition exists based on technological innovations, product performance, and intellectual property rights. The company invests heavily in research and development, with $11.4 billion allocated in 2019, reflecting a commitment to creating life-enhancing innovations and addressing evolving healthcare needs. The company's operational flexibility is enhanced through strategic collaborations and investments in critical capabilities, technologies, and solutions necessary for future product portfolios. The company relies on both internal IT systems and those of third parties to process and store sensitive data, which poses risks related to information security and cybersecurity threats. The company continually assesses these threats and invests to increase internal protection, detection, and response capabilities. The management emphasizes the importance of mobilizing and deploying IT-based resources in combination with leveraging other resources and capabilities to transform the firm into a competitive force. The company has not experienced material impacts from cybersecurity attacks to date; however, the potential for adverse effects remains due to the evolving nature of threats. The company’s extensive operations and business activity outside the U.S. are accompanied by financial, economic, and political risks, including fluctuations in currency exchange rates that impact revenues and expenses. The company monitors economic conditions and strives to maintain profitability through cost reduction programs and productivity improvements. The company's competitive environment requires substantial investments in continuing research, particularly in the development of new and innovative products. The company also faces challenges in maintaining customer demand for its consumer products, which involves significant expenditures for advertising and promotion. The company is subject to extensive regulation, investigations, and legal actions, which can impose significant compliance costs and expose it to government investigations and penalties. The company’s reliance on third-party manufacturers introduces risks related to regulatory compliance and quality assurance, which can impact product availability and sales. The company has a policy of pricing products responsibly in response to rising healthcare costs, which may affect market dynamics and consumer choice. The company’s ability to secure and defend intellectual property rights is essential, as challenges from competitors regarding patent validity can adversely affect competitive positioning and sales. The company’s organizational capabilities are critical in navigating the complexities of the healthcare landscape, including regulatory scrutiny and the need for operational agility. The company’s strategic management practices focus on leveraging its extensive resources to innovate and execute with excellence, ensuring alignment with organizational goals and market demands.